You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

EXIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Exidine patents expire, and what generic alternatives are available?

Exidine is a drug marketed by Xttrium and is included in four NDAs.

The generic ingredient in EXIDINE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Exidine

A generic version of EXIDINE was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EXIDINE?
  • What are the global sales for EXIDINE?
  • What is Average Wholesale Price for EXIDINE?
Drug patent expirations by year for EXIDINE
Pharmacology for EXIDINE
Physiological EffectDecreased Cell Wall Integrity

US Patents and Regulatory Information for EXIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xttrium EXIDINE chlorhexidine gluconate AEROSOL, METERED;TOPICAL 019127-001 Dec 24, 1984 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019125-001 Dec 24, 1984 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019422-001 Dec 17, 1985 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xttrium EXIDINE chlorhexidine gluconate SOLUTION;TOPICAL 019421-001 Dec 17, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.